LEVO-T Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Levo-t patents expire, and what generic alternatives are available?
Levo-t is a drug marketed by Cediprof Inc and is included in one NDA.
The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levo-t
A generic version of LEVO-T was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for LEVO-T
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 163 |
Patent Applications: | 3,761 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LEVO-T |
What excipients (inactive ingredients) are in LEVO-T? | LEVO-T excipients list |
DailyMed Link: | LEVO-T at DailyMed |


Pharmacology for LEVO-T
Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for LEVO-T
US Patents and Regulatory Information for LEVO-T
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-007 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-004 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LEVO-T
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-007 | Mar 1, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-003 | Mar 1, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LEVO-T
See the table below for patents covering LEVO-T around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2003528931 | ⤷ Try a Trial | |
Australia | 5295301 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 0174448 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |